Beyond LDL-cholesterol: HDL-cholesterol as a target for atherosclerosis prevention

K G Parhofer1

  • 1Department of Internal Medicine II, Klinikum Grosshadern, Ludwig-Maximilians University, Munich, Germany. Klaus.Parhofer@med.uni-muenchen.de

Insights

Dyslipoproteinemias, like high LDL-cholesterol and low HDL-cholesterol, are key to atherosclerosis. While LDL reduction is primary, optimizing all lipid parameters, including HDL, may benefit many patients.

Area of Science:

  • Cardiovascular Medicine
  • Lipid Metabolism
  • Atherosclerosis Research

Background:

  • Dyslipoproteinemias, including elevated LDL-cholesterol, reduced HDL-cholesterol, elevated triglycerides, and elevated lipoprotein(a), are central to atherosclerosis development.
  • Elevated LDL (low-density lipoprotein) is pro-atherogenic, promoting oxidative and inflammatory processes in the arterial wall.
  • HDL (high-density lipoprotein) is anti-atherogenic, facilitating cholesterol efflux, modulating atherogenic lipoproteins, and supporting endothelial function.

Purpose of the Study:

  • To review the role of various dyslipoproteinemias in atherosclerosis.
  • To discuss the therapeutic strategies focusing on LDL reduction and HDL elevation.
  • To highlight the potential benefits of combination therapy for optimizing lipid profiles.

Main Methods:

  • Literature review of dyslipoproteinemias and their role in atherosclerosis.
  • Analysis of current therapeutic approaches targeting lipid parameters.
  • Evaluation of the impact of LDL reduction and HDL elevation on cardiovascular outcomes.

Main Results:

  • Elevated LDL is pro-atherogenic, while HDL is anti-atherogenic.
  • Current therapy prioritizes LDL reduction, with less focus on HDL elevation.
  • Fibrates and nicotinic acid/niacin effectively increase HDL-cholesterol and have shown benefits in large studies.

Conclusions:

  • Statin-based LDL reduction is the cornerstone for patients with established atherosclerosis or high risk.
  • Combination therapy targeting multiple lipid parameters may offer additional benefits.
  • Development of new HDL-raising drugs is ongoing, expanding therapeutic options.

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Lipids: Dietary Sources and Requirements01:18

Lipids: Dietary Sources and Requirements

Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ meats, shellfish,...
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...